Medcitynews

This new approach is helping payors and providers unlock new value from their VBC initiatives while offering more effective and condition-specific treatment for patients.  The post Evolving Markets, Innovative Solutions: The Rise of Specialty VBC appeared first on MedCity News.

In addition to meeting the main safety and tolerability goal, MieraGTx Holdings’ gene therapy for Parkinson’s disease also showed signs of efficacy. The one-time treatment is intended to reprogram dysfunctional brain circuits. The post On Heels of Positive Parkinson’s Gene Therapy Data, MeiraGTx Looks Ahead to Pivotal Test appeared first on MedCity News.

Generative AI-powered voice platform Parakeet Health announced its launch and $3 million in seed funding. The startup seeks to automate many of the interactions that patients have with their doctor’s staff, such as scheduling appointments and answering billing questions. The post Parakeet Health Flies Onto The Scene to Automate Healthcare Call Centers appeared first on…

Headspace recently introduced Ebb, an empathetic AI companion. It helps users reflect and sort through their emotions, and provides recommendations for mental health content. The post Headspace Introduces AI Companion To Support Patients Through ‘Ebbs and Flows’ of Life appeared first on MedCity News.

PurpleLab® stands out from others in this sector by providing its data analytics services to several different groups of users across healthcare and pharma companies. The post The Future of Hospitals and Pharma Companies Will Depend on Strength of Healthcare Analytics Insights appeared first on MedCity News.

Payers and providers alike are struggling with data interoperability. It’s clear that a more unified approach to data management is essential for payers to effectively navigate the complexities of value-based care. The post Finding the Cure for Data Interoperability in Value-Based Care appeared first on MedCity News.

Lundbeck says Longboard Pharmaceuticals’ drug, bexicaserin, has potential applications in a range of rare epilepsies. Last month, the biotech began a Phase 3 clinical trial testing the drug in Dravet syndrome. The post Lundbeck’s Neuro-Rare Pipeline Lands Cornerstone Drug via $2.6B Longboard Pharma Acquisition appeared first on MedCity News.

Suki’s $70 million Series D financing round was led by Hedosophia and included participation from Venrock, March Capital, Flare Capital, Breyer Capital and inHealth Ventures. The post Suki Secures $70M To Expand AI Offerings appeared first on MedCity News.

We need to equip pharmacists with technology that can help them to make impactful clinical interventions in the pharmacy and reimburse them for these services, which would help to address the provider shortage. The post Community Pharmacies Fill Critical Healthcare Gaps in Rural Areas — Here’s How We Can Empower and Support Them appeared first…